Patients with elevated cTnT achieved on average 4.1 [SD 1.2] of the seven general treatment targets (excluding HbA1c in patients with diabetes) for secondary prevention while patients with low cTnT achieved 4.3 [SD 1.1] treatment targets (p = 0.01) within one year after MI, PCI or CABG. Here, TNNT2 is linked to diabetes mellitus.